RecruitingNCT06972368
Home-Based tDCS for Depression in BPD
In MontrealPersonality disorders, DepressionDevice studyAges 18–65
Study directory
Back to overviewDepression studies
Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
RecruitingNCT04685148
Maternal Mental Health study
In CopenhagenDepressionMedication studyAges 18–45
RecruitingNCT07159061
Neurofeedback to Treat Depression - 2
In PhiladelphiaDepressionBehavioural studyAges 18–65
Not Yet RecruitingNCT07364981
Gaze Contingent Attentional Reinforcement in Major Depressive Disorder
This study isn't recruiting yet.
In Tel AvivDepressionBehavioural studyAges 18–65
Enrolling By InvitationNCT06821646
Investigating the Brain's Physiological Responses in Depression and Autism, Using Transcranial Magnetic Stimulation and Electroencephalography
This study is by invitation only.
In TaipeiDepressionObservational studyAges 20–50
RecruitingNCT03522545
Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Depression in bipolarity
In HoustonDepression, BipolarityPlacebo comparisonAges 18–65
RecruitingACTRN12623001004651
Evaluating the management of treatment resistant depression with psychedelic (psilocybin) assisted psychotherapy (EMPACT)
What is this study about?
In AustraliaThis study evaluates the effectiveness of psychotherapy for people with depression.
DepressionInterventional studyAges 18–80
RecruitingACTRN12623000817640
Ketamine and Behavioural Activation Therapy study
In New ZealandDepressionInterventional studyAges 18–65
RecruitingACTRN12625000528459
Optimised Transcranial Magnetic Stimulation for Depression (OptiTMS)
In AustraliaDepressionInterventional studyAges 18–65
Not Yet RecruitingACTRN12626000475347
A study of Behaviour Activation Therapy combined with ketamine treatment for people with treatment-resistant depression
This study isn't recruiting yet.
Multiple locations, including CamperdownDepressionInterventional studyAges 18+
RecruitingNCT05680220
40 Hz Light Neurostimulation for people with Depression (FELIX)
In CopenhagenDepressionDevice studyAges 18–75
RecruitingNCT06319378
Cancer Related Major Depression Treated With a Single Dose of Psilocybin
What is this study about?
Multiple locations, including GothenburgResearchers are comparing psilocybin 25 mg sod and psilocybin 1 mg sod to find out how the approaches affect depression symptoms in people with depression.
DepressionMedication studyAges 20–80
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.